Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases.
The company has made two announcements this week that improve its chances of selling its lead drug candidate Galidesivir to the US government.
In particular, the company has appointed two highly experienced executives that add funding and procurement capability, as well as additional knowledge of Galidesivir.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
Island Pharmaceuticals Ltd - Key appointments amidst an Ebola outbreak